Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
08 Jul 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]US Exclusivities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Indigotindisulfonate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indigotindisulfonate Sodium, including repackagers and relabelers. The FDA regulates Indigotindisulfonate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indigotindisulfonate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indigotindisulfonate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indigotindisulfonate Sodium supplier is an individual or a company that provides Indigotindisulfonate Sodium active pharmaceutical ingredient (API) or Indigotindisulfonate Sodium finished formulations upon request. The Indigotindisulfonate Sodium suppliers may include Indigotindisulfonate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Indigotindisulfonate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indigotindisulfonate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Indigotindisulfonate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Indigotindisulfonate Sodium DMFs exist exist since differing nations have different regulations, such as Indigotindisulfonate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indigotindisulfonate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Indigotindisulfonate Sodium USDMF includes data on Indigotindisulfonate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indigotindisulfonate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indigotindisulfonate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Indigotindisulfonate Sodium Drug Master File in Japan (Indigotindisulfonate Sodium JDMF) empowers Indigotindisulfonate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Indigotindisulfonate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Indigotindisulfonate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Indigotindisulfonate Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indigotindisulfonate Sodium Drug Master File in Korea (Indigotindisulfonate Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indigotindisulfonate Sodium. The MFDS reviews the Indigotindisulfonate Sodium KDMF as part of the drug registration process and uses the information provided in the Indigotindisulfonate Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indigotindisulfonate Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indigotindisulfonate Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indigotindisulfonate Sodium suppliers with KDMF on PharmaCompass.
A Indigotindisulfonate Sodium written confirmation (Indigotindisulfonate Sodium WC) is an official document issued by a regulatory agency to a Indigotindisulfonate Sodium manufacturer, verifying that the manufacturing facility of a Indigotindisulfonate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Indigotindisulfonate Sodium APIs or Indigotindisulfonate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Indigotindisulfonate Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Indigotindisulfonate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Indigotindisulfonate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Indigotindisulfonate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Indigotindisulfonate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Indigotindisulfonate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Indigotindisulfonate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Indigotindisulfonate Sodium suppliers with NDC on PharmaCompass.
Indigotindisulfonate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indigotindisulfonate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indigotindisulfonate Sodium GMP manufacturer or Indigotindisulfonate Sodium GMP API supplier for your needs.
A Indigotindisulfonate Sodium CoA (Certificate of Analysis) is a formal document that attests to Indigotindisulfonate Sodium's compliance with Indigotindisulfonate Sodium specifications and serves as a tool for batch-level quality control.
Indigotindisulfonate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Indigotindisulfonate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indigotindisulfonate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Indigotindisulfonate Sodium EP), Indigotindisulfonate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indigotindisulfonate Sodium USP).
LOOKING FOR A SUPPLIER?
Comment (3)
